This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Nanotechnol. 2020, 11, 354–369, doi:10.3762/bjnano.11.26
Figure 1: (A) Gel retardation assay for polyplexes formed with different ratios (v/v) of PVI/siRNA. Ethidium ...
Figure 2: (A) FTIR spectra of free siRNA, PVI and the polyplex recorded in ATR mode between 4000 and 400 cm−1...
Figure 3: (A) Intracellular uptake of the polyplex monitored by using laser scanning confocal microscopy afte...
Figure 4: The endosomal escape of the polyplex after 4 h of incubation in A549 cells visualized using endotra...
Figure 5: Expression of vascular endothelial growth factor (VEGF) mRNA in A549 cells analyzed by RT-PCR. The ...
Figure 6: VEGF, HIF-1alpha and β-actin protein expression levels, obtained from Western blot, in A549 cells a...
Figure 7: Cell viability of A549 cancer cells after treatment with carrier systems (blank carrier and the pol...
Figure 8: Flow cytometry analysis of A549 cells treated for 4 h with VEGF siRNA and analyzed 48 h after treat...
Figure 9: Morphology of A549 cells after treatment with blank PVI nanoparticles or polyplex. (A) Control; (B)...
Figure 10: (A) Migration of A549 cells 48 h after treatment with free siRNA, blank polymer nanoparticles, poly...
Figure 11: (A) Migration of A549 cells analyzed using Boyden chamber assay 48 h after treatment. a: Control; b...
Figure 12: Viability of A549 cells after silencing VEGF using free siRNA or the polyplex for 4 h followed by t...
Figure 13: Morphology of HUVECs cultured in serum-free medium after (A) 0 h, (B) 24 h, and (C) 48 h; (D) contr...
Figure 14: (A): Hierarchical clustering obtained from the microarray analysis (49,372 genes). Each row represe...